Global Generic Drugs Market Growth (Status and Outlook) 2023-2029

Global Generic Drugs Market Growth (Status and Outlook) 2023-2029

A generic drug is a pharmaceutical drug that is equivalent to a brand-name product in dosage, strength, route of administration, quality, performance, and intended use. The term may also refer to any drug marketed under its chemical name without advertising, or to the chemical makeup of a drug rather than the brand name under which the drug is sold.

LPI (LP Information)' newest research report, the “Generic Drugs Industry Forecast” looks at past sales and reviews total world Generic Drugs sales in 2022, providing a comprehensive analysis by region and market sector of projected Generic Drugs sales for 2023 through 2029. With Generic Drugs sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Generic Drugs industry.

This Insight Report provides a comprehensive analysis of the global Generic Drugs landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Generic Drugs portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Generic Drugs market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Generic Drugs and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Generic Drugs.

The global Generic Drugs market size is projected to grow from US$ 306650 million in 2022 to US$ 546690 million in 2029; it is expected to grow at a CAGR of 8.6% from 2023 to 2029.

Market competition is not intense. Teva, Novartis – Sandoz, Mylan, Sun Pharmaceutical and Aspen are the leaders of the industry, with about 19% market shares.

North America is the largest consumption place, with a consumption market share nearly 44%. Following North America, Europe is the second largest consumption place with the consumption market share of 18%.

This report presents a comprehensive overview, market shares, and growth opportunities of Generic Drugs market by product type, application, key players and key regions and countries.

Market Segmentation:

Segmentation by type

Prescription

Non-Prescription Drugs

Segmentation by application

Hospital

Clinic

Others

This report also splits the market by region:

Americas

United States

Canada

Mexico

Brazil

APAC

China

Japan

Korea

Southeast Asia

India

Australia

Europe

Germany

France

UK

Italy

Russia

Middle East & Africa

Egypt

South Africa

Israel

Turkey

GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.

Teva

Novartis - Sandoz

Mylan

Sun Pharmaceutical

Aspen

Fresenius Kabi

Pfizer (Hospira)

Sanofi

Aurobindo

Lupin

Dr. Reddy's

Apotex

Cipla

ENDO (Par Pharmaceutical)

Stada Arzneimittel

Krka Group

Nichi-Iko Pharmaceutical

Valeant

Zydus Cadila

Hikma

Pharmaniaga Berhad

Hovid Berhad

Duopharma Biotech

Kotra Pharma

HOE Pharmaceutical

Y.S.P. Industries

Please note: The report will take approximately 2 business days to prepare and deliver.